Bupropion
Back to searchMolecule Structure
Scientific Name
Bupropion
Description of the Drug
Bupropion is a norepinephrine and dopamine reuptake inhibitor used in the treatment of major depressive disorder (MDD), seasonal affective disorder (SAD), and as an aid to smoking cessation.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01156
http://www.drugbank.ca/drugs/DB01156
Brand Name(s)
Not Available
Company Owner(s)
Glaxosmithkline, Jubilant Generics Ltd, Invagen Pharmaceuticals Inc, Watson Laboratories Inc, Anchen Pharmaceuticals Inc, Yichang Humanwell Pharmaceutical Co Ltd, Granules Pharmaceuticals Inc, Nalpropion Pharmaceuticals Llc, Mylan Pharmaceuticals Inc, Impax Laboratories Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Dopamine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL238 |
Norepinephrine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL222 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL38777 | |||||
PharmGKB | PA448687 | |||||
Human Metabolome Database | HMDB0001510 | |||||
DrugBank | DB01156 | |||||
PubChem: Thomson Pharma | 15196401 | |||||
PubChem | 444 | |||||
LINCS | LSM-1267 | |||||
Nikkaji | J283.224K | |||||
BindingDB | 50048392 | |||||
EPA CompTox Dashboard | DTXSID7022706 | |||||
DrugCentral | 435 | |||||
Brenda | 19651 | |||||
ChemicalBook | CB7202445 | |||||
Guide to Pharmacology | 7135 | |||||
rxnorm | BUPROPION HYDROCHLORIDE | WELLBUTRIN | BUPROPION | APLENZIN | ZYBAN | BUPROPION HYDROBROMIDE |
KEGG Ligand | C06860 | |||||
ChEBI | 3219 |